Increasing oversight of API manufacturing through international collaboration

April 12, 2018 – The European Medicines Agency (EMA) and its European and international partners have successfully strengthened their interactions to improve the oversight of active pharmaceutical ingredient (API) manufacturers worldwide, as highlighted in the International API inspection programme report for 2011-2016, published today. APIs are the substances responsible for the activity of a medicine. This international collaboration allows EMA, several European … (leggi tutto)